See the DrugPatentWatch profile for vascepa

Vascepa (icosapent ethyl) is a prescription medication approved by the FDA to help reduce the risk of cardiovascular events, such as heart attacks and strokes, in certain patients [1]. Common side effects of Vascepa include joint pain, swelling, and soreness [1][2].

More rare side effects of Vascepa include an increased risk of bleeding, allergic reactions, and liver enzyme abnormalities [2]. It is important to note that the risk of these side effects may increase when Vascepa is taken in combination with other medications that affect blood clotting, such as warfarin [2].

Additionally, it is important to inform your healthcare provider of any pre-existing medical conditions, as Vascepa may not be suitable for individuals with certain health issues, such as liver or pancreas disorders [2].

It is also important to note that, according to DrugPatentWatch.com, Vascepa's patent is set to expire in 2028, which may lead to the introduction of generic versions of the drug [3].

In summary, common side effects of Vascepa include joint pain, swelling, and soreness, while more rare side effects include an increased risk of bleeding, allergic reactions, and liver enzyme abnormalities. Patients should inform their healthcare provider of any pre-existing medical conditions and be aware of the drug's patent expiration date.

Sources:
[1] "Vascepa (Icosapent Ethyl) Capsules, for Oral Use." FDA, FDA, 2019, [www.accessdata.fda.gov/drugsatfda_docs/label/2019/202923s000lbl.pdf](http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202923s000lbl.pdf).
[2] "Icosapent Ethyl (Vascepa): Side Effects, Interactions, Warning, and Dosing." RxList, RxList, 2021, [www.rxlist.com/icosapent_ethyl_vascepa/drugs-condition.htm](http://www.rxlist.com/icosapent_ethyl_vascepa/drugs-condition.htm).
[3] "Vascepa (Icosapent Ethyl) Patent Expiration & Generics." DrugPatentWatch, DrugPatentWatch, 2021, [www.drugpatentwatch.com/drugs/vascepa](http://www.drugpatentwatch.com/drugs/vascepa).